Prognostic significance of galectin‐3 expression in patients with resected NSCLC treated with platinum‐based adjuvant chemotherapy

Abstract Background Galectin‐3 (GAL3), a protein encoded by the LGALS3 gene, plays diverse roles in cancer initiation, progression, and drug resistance. Accordingly, high GAL3 expression in tumor cells is associated with poor prognosis in non‐small cell lung cancer (NSCLC). However, the prognostic i...

Полное описание

Библиографические подробности

Главные авторы:	Seiichiro Kusuhara, Satoshi Igawa, Masaaki Ichinoe, Ryo Nagashio, Yuki Kuchitsu, Yasuhiro Hiyoshi, Kazu Shiomi, Yoshiki Murakumo, Makoto Saegusa, Yukitoshi Satoh, Yuichi Sato, Katsuhiko Naoki
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wiley 2021-05-01
Серии:	Thoracic Cancer
Предметы:	adjuvant chemotherapy biomarker galectin‐3 immunohistochemistry non‐small cell lung cancer
Online-ссылка:	https://doi.org/10.1111/1759-7714.13945
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!